Regent Investment Management Cut Ani Pharmaceuticals (ANIP) Holding; Jet Capital Investors LP Raised By $11.70 Million Its Firstenergy (FE) Holding

FirstEnergy Corp. (NYSE:FE) Logo

Jet Capital Investors LP increased Firstenergy Corp (FE) stake by 37.63% reported in 2019Q2 SEC filing. Jet Capital Investors LP acquired 278,605 shares as Firstenergy Corp (FE)’s stock rose 4.82%. The Jet Capital Investors LP holds 1.02M shares with $43.62M value, up from 740,395 last quarter. Firstenergy Corp now has $25.99B valuation. The stock increased 0.75% or $0.36 during the last trading session, reaching $48.1. About 1.80 million shares traded. FirstEnergy Corp. (NYSE:FE) has risen 25.99% since December 4, 2018 and is uptrending. It has outperformed by 25.99% the S&P500. Some Historical FE News: 10/05/2018 – Fitch Withdraws Ratings for FirstEnergy Solutions and Subs; 25/04/2018 – FIRSTENERGY CORP FE.N : CITIGROUP RAISES TARGET PRICE TO $34 FROM $32; 25/04/2018 – FIRSTENERGY SOLUTIONS: LETTER AFFIRMS DEACTIVATION PLANS; 06/04/2018 – Penelec to Conduct Storm Restoration Drill to Help Employees Prepare for Severe Weather Events; 23/04/2018 – FirstEnergy Bond Trading 18x Average; Clients Net Buyers; 05/04/2018 – After-hours buzz: PSMT, URBN, FE & more; 02/04/2018 – FIRSTENERGY SUES ENERGY REGULATOR AFTER FILING FOR BANKRUPTCY; 23/04/2018 – FIRSTENERGY SAYS FES SETTLEMENT WITHIN ITS PLANNED RANGE; 08/05/2018 – MOODY’S ASSIGNS FIRST-TIME BAA1 SENIOR UNSECURED RATING TO MID-ATLANTIC INTERSTATE TRANSMISSION LLC; RATING OUTLOOK STABLE; 05/04/2018 – Trump Says Emergency Aid Sought by FirstEnergy to Be Examined

Regent Investment Management Llc decreased Ani Pharmaceuticals (ANIP) stake by 9.36% reported in 2019Q2 SEC filing. Regent Investment Management Llc sold 4,030 shares as Ani Pharmaceuticals (ANIP)’s stock rose 20.43%. The Regent Investment Management Llc holds 39,009 shares with $3.21M value, down from 43,039 last quarter. Ani Pharmaceuticals now has $724.86 million valuation. The stock increased 0.71% or $0.42 during the last trading session, reaching $59.95. About 76,632 shares traded. ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) has risen 25.49% since December 4, 2018 and is uptrending. It has outperformed by 25.49% the S&P500. Some Historical ANIP News: 07/05/2018 – ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/lmpax; 27/04/2018 – ANI PHARMACEUTICALS – UPON DEAL CLOSING , ANI TO BUY PRODUCT PORTFOLIO CONSISTING OF 5 APPROVED GENERIC ANDAS, 1 PIPELINE PRODUCT, ERYTHROMYCIN IR TABLETS; 18/04/2018 – ANI Pharmaceuticals Announces Approval of Morphine Sulfate Oral Solution; 27/04/2018 – ANI PHARMACEUTICALS INC – ANI WILL ACQUIRE LICENSE, SUPPLY & DISTRIBUTION AGREEMENT FOR A SECOND PIPELINE PRODUCT, DICLOFENAC-MISOPROSTOL DR TABLETS; 27/04/2018 – ANI Pharmaceuticals Signs Definitive Agreements to Acquire Generic Products and Assets from Amneal/Impax; 27/04/2018 – ANI PHARMACEUTICALS TO BUY GENERIC PRODUCTS FROM AMNEAL, IMPAX; 08/05/2018 – ANI Pharmaceuticals 1Q Adj EPS $1.32; 08/05/2018 – ANI PHARMACEUTICALS INC – REAFFIRMS GUIDANCE FOR FULL YEAR 2018; 27/04/2018 – ANI Pharmaceuticals Signs Definitive Agreements to Acquire Generic Products and Assets from Amneal/lmpax; 18/04/2018 – ANIP SAYS FDA APPROVES MORPHINE SULFATE ORAL SOLUTION

Investors sentiment decreased to 1.3 in Q2 2019. Its down 0.66, from 1.96 in 2019Q1. It is negative, as 8 investors sold ANIP shares while 41 reduced holdings. 29 funds opened positions while 67 raised stakes. 8.26 million shares or 10.11% more from 7.50 million shares in 2019Q1 were reported. Comerica Natl Bank reported 7,928 shares. Ameritas Ptnrs owns 781 shares. South Dakota Investment Council holds 0% or 1,000 shares in its portfolio. Moreover, California State Teachers Retirement Systems has 0% invested in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP). Morgan Stanley owns 0% invested in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) for 39,244 shares. Globeflex Cap LP holds 27,702 shares or 0.47% of its portfolio. Texas Permanent School Fund accumulated 5,718 shares. Cornercap Inv Counsel Incorporated owns 24,805 shares for 0.27% of their portfolio. Sg Americas Securities Ltd Llc stated it has 0% in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP). Intrust Bancshares Na owns 3,802 shares. Manufacturers Life Com The invested 0% in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP). Captrust Advisors stated it has 0% in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP). Systematic Fincl Mgmt Ltd Partnership holds 0.04% or 12,895 shares in its portfolio. Nuveen Asset Mgmt Limited Co reported 86,019 shares. Farmers & Merchants Invests invested in 0% or 130 shares.

Analysts await ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) to report earnings on February, 26. They expect $1.02 earnings per share, down 15.00% or $0.18 from last year’s $1.2 per share. ANIP’s profit will be $12.33 million for 14.69 P/E if the $1.02 EPS becomes a reality. After $1.07 actual earnings per share reported by ANI Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -4.67% negative EPS growth.

More notable recent ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) news were published by: Nasdaq.com which released: “ANI Pharmaceuticals (ANIP) Lags Q3 Earnings and Revenue Estimates – Nasdaq” on November 06, 2019, also Nasdaq.com with their article: “Moving Average Crossover Alert: ANI Pharmaceuticals – Nasdaq” published on December 04, 2019, Nasdaq.com published: “New Strong Sell Stocks for December 4th – Nasdaq” on December 04, 2019. More interesting news about ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) were released by: Finance.Yahoo.com and their article: “Estimating The Intrinsic Value Of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) – Yahoo Finance” published on November 11, 2019 as well as Nasdaq.com‘s news article titled: “ANI Pharma To Present At Evercore ISI HealthCONx Conference; Webcast At 10:15 AM – Nasdaq” with publication date: December 03, 2019.

Regent Investment Management Llc increased Cisco Systems Inc (NASDAQ:CSCO) stake by 10,445 shares to 97,203 valued at $5.32M in 2019Q2. It also upped Becton Dickinson&Co (NYSE:BDX) stake by 2,119 shares and now owns 5,456 shares. Williams Companies (NYSE:WMB) was raised too.

Since August 9, 2019, it had 0 insider purchases, and 2 insider sales for $4.94 million activity. MERIDIAN VENTURE PARTNERS II LP also sold $516,984 worth of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) on Monday, August 19.

Among 2 analysts covering ANI Pharmaceuticals (NASDAQ:ANIP), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. ANI Pharmaceuticals has $7600 highest and $7500 lowest target. $75.50’s average target is 25.94% above currents $59.95 stock price. ANI Pharmaceuticals had 4 analyst reports since September 12, 2019 according to SRatingsIntel. The company was maintained on Thursday, November 7 by Raymond James.

More notable recent FirstEnergy Corp. (NYSE:FE) news were published by: Finance.Yahoo.com which released: “Hedge Funds Aren’t Crazy About FirstEnergy Corp. (FE) Anymore – Yahoo Finance” on December 03, 2019, also Finance.Yahoo.com with their article: “Should You Be Excited About FirstEnergy Corp.’s (NYSE:FE) 17% Return On Equity? – Yahoo Finance” published on November 07, 2019, Fool.com published: “FirstEnergy Corp (FE) Q3 2019 Earnings Call Transcript – Motley Fool” on November 04, 2019. More interesting news about FirstEnergy Corp. (NYSE:FE) were released by: Crainscleveland.com and their article: “FirstEnergy Solutions to become Energy Harbor, keep headquarters in Akron – Crain’s Cleveland Business” published on November 25, 2019 as well as Businesswire.com‘s news article titled: “FirstEnergy’s Pennsylvania Default Service Program DSP-V Auctions: Information Session for Prospective Bidders on Wednesday, December 4, 2019 – Business Wire” with publication date: December 03, 2019.

Investors sentiment decreased to 1.15 in Q2 2019. Its down 0.18, from 1.33 in 2019Q1. It dived, as 38 investors sold FE shares while 145 reduced holdings. 56 funds opened positions while 188 raised stakes. 474.43 million shares or 2.81% more from 461.44 million shares in 2019Q1 were reported. Mason Street Advsr Limited, Wisconsin-based fund reported 72,004 shares. Gulf Int Bancorp (Uk), a United Kingdom-based fund reported 120,785 shares. 191,184 were reported by Cbre Clarion Limited Liability Corp. Ibm Retirement Fund reported 11,964 shares. Cornerstone Advisors accumulated 565 shares. Proshare Advsr Ltd Llc reported 0.02% in FirstEnergy Corp. (NYSE:FE). Cubist Systematic Strategies Lc has 44,649 shares. Adage Capital Ptnrs Limited Liability Corporation holds 0.32% or 3.03 million shares in its portfolio. San Francisco Sentry Inv Grp (Ca) holds 0% or 40 shares in its portfolio. Cullinan Assocs stated it has 0.02% of its portfolio in FirstEnergy Corp. (NYSE:FE). Sandy Spring Comml Bank holds 449 shares or 0% of its portfolio. 21,187 were reported by First Midwest National Bank Trust Division. Huber Cap Management Ltd Limited Liability Company holds 0.62% or 122,600 shares in its portfolio. Trust Of Vermont has 0% invested in FirstEnergy Corp. (NYSE:FE). 290 are owned by First Fincl In.

Among 5 analysts covering FirstEnergy (NYSE:FE), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. FirstEnergy has $5600 highest and $4600 lowest target. $51.80’s average target is 7.69% above currents $48.1 stock price. FirstEnergy had 14 analyst reports since June 20, 2019 according to SRatingsIntel. UBS maintained it with “Buy” rating and $55 target in Wednesday, October 23 report. The rating was upgraded by Mizuho on Monday, November 25 to “Buy”. The stock has “Equal-Weight” rating by Morgan Stanley on Tuesday, November 5. KeyBanc Capital Markets maintained the shares of FE in report on Thursday, June 20 with “Buy” rating. As per Monday, November 25, the company rating was maintained by UBS. Citigroup maintained it with “Hold” rating and $49 target in Thursday, October 10 report. The stock of FirstEnergy Corp. (NYSE:FE) earned “Buy” rating by Mizuho on Tuesday, August 13. The stock has “Overweight” rating by KeyBanc Capital Markets on Monday, October 21.

FirstEnergy Corp. (NYSE:FE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.